Fidelity National Financial (NYSE:FNF – Get Free Report) is projected to post its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect the company to announce earnings of $1.51 per share and revenue of $3.6590 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 20, 2026 at 11:00 AM ET.
Fidelity National Financial Price Performance
Shares of NYSE:FNF opened at $57.17 on Thursday. The company has a current ratio of 0.25, a quick ratio of 0.25 and a debt-to-equity ratio of 0.47. The stock has a market cap of $16.07 billion, a PE ratio of 13.79, a price-to-earnings-growth ratio of 0.72 and a beta of 0.98. The stock’s fifty day simple moving average is $55.30 and its two-hundred day simple moving average is $57.22. Fidelity National Financial has a 1-year low of $50.61 and a 1-year high of $66.72.
Insider Buying and Selling
In related news, Director Halim Dhanidina sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, January 5th. The shares were sold at an average price of $55.90, for a total value of $335,400.00. Following the sale, the director directly owned 13,186 shares of the company’s stock, valued at $737,097.40. This trade represents a 31.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Daniel D. Lane sold 6,367 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $57.63, for a total value of $366,930.21. Following the completion of the sale, the director owned 276,308 shares of the company’s stock, valued at $15,923,630.04. The trade was a 2.25% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 5.50% of the company’s stock.
Institutional Trading of Fidelity National Financial
Wall Street Analysts Forecast Growth
A number of equities analysts have recently weighed in on FNF shares. Weiss Ratings restated a “buy (b-)” rating on shares of Fidelity National Financial in a research note on Monday, December 29th. Wall Street Zen lowered shares of Fidelity National Financial from a “buy” rating to a “hold” rating in a research report on Monday, January 26th. National Bank Financial set a $63.00 target price on shares of Fidelity National Financial in a research report on Tuesday, January 6th. Stephens initiated coverage on shares of Fidelity National Financial in a report on Friday, November 14th. They issued an “overweight” rating on the stock. Finally, Keefe, Bruyette & Woods increased their price objective on Fidelity National Financial from $70.00 to $72.00 and gave the company an “outperform” rating in a report on Thursday, December 18th. Three investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, Fidelity National Financial has an average rating of “Moderate Buy” and an average target price of $68.25.
Check Out Our Latest Stock Analysis on Fidelity National Financial
Fidelity National Financial Company Profile
Fidelity National Financial (NYSE: FNF) is a leading provider of title insurance and transaction services to the real estate and mortgage industries. The company underwrites title insurance policies that protect property owners and lenders against title defects, liens, and other encumbrances. Alongside its core title insurance operations, FNF offers escrow and closing services, e-recording solutions, and real estate data and analytics through a network of agents and underwriters.
FNF operates through two primary segments: Title Insurance and Specialty Insurance and Services.
Recommended Stories
- Five stocks we like better than Fidelity National Financial
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Fidelity National Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fidelity National Financial and related companies with MarketBeat.com's FREE daily email newsletter.
